nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—TDO2—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.115	0.342	CbGpPWpGaD
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—esophageal cancer	0.0834	0.141	CcSEcCtD
Nalidixic Acid—Papilloedema—Cisplatin—esophageal cancer	0.0551	0.0934	CcSEcCtD
Nalidixic Acid—Lomefloxacin—ABCC2—esophageal cancer	0.0435	0.594	CrCbGaD
Nalidixic Acid—Joint stiffness—Capecitabine—esophageal cancer	0.0428	0.0725	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—ALDH2—esophageal cancer	0.0347	0.103	CbGpPWpGaD
Nalidixic Acid—Norfloxacin—CYP2A6—esophageal cancer	0.0298	0.407	CrCbGaD
Nalidixic Acid—Optic neuritis—Cisplatin—esophageal cancer	0.0285	0.0483	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.0263	0.0782	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.0248	0.0736	CbGpPWpGaD
Nalidixic Acid—Blister—Capecitabine—esophageal cancer	0.0179	0.0304	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Cisplatin—esophageal cancer	0.0141	0.0239	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0131	0.0223	CcSEcCtD
Nalidixic Acid—Swelling—Capecitabine—esophageal cancer	0.0106	0.018	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0104	0.0176	CcSEcCtD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.00989	0.0294	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.00989	0.0294	CbGpPWpGaD
Nalidixic Acid—Dermatitis bullous—Capecitabine—esophageal cancer	0.00981	0.0166	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00961	0.0163	CcSEcCtD
Nalidixic Acid—Diplopia—Capecitabine—esophageal cancer	0.00938	0.0159	CcSEcCtD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00862	0.0256	CbGpPWpGaD
Nalidixic Acid—Visual impairment—Cisplatin—esophageal cancer	0.00848	0.0144	CcSEcCtD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00788	0.0234	CbGpPWpGaD
Nalidixic Acid—Erythema—Cisplatin—esophageal cancer	0.00766	0.013	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Capecitabine—esophageal cancer	0.0074	0.0125	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00721	0.0122	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00717	0.0121	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00708	0.012	CcSEcCtD
Nalidixic Acid—Leukopenia—Cisplatin—esophageal cancer	0.00686	0.0116	CcSEcCtD
Nalidixic Acid—Convulsion—Cisplatin—esophageal cancer	0.00664	0.0112	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Cisplatin—esophageal cancer	0.00625	0.0106	CcSEcCtD
Nalidixic Acid—Visual impairment—Capecitabine—esophageal cancer	0.00625	0.0106	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Capecitabine—esophageal cancer	0.00613	0.0104	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cisplatin—esophageal cancer	0.00612	0.0104	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—esophageal cancer	0.00597	0.0101	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0057	0.00965	CcSEcCtD
Nalidixic Acid—Erythema—Capecitabine—esophageal cancer	0.00565	0.00957	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cisplatin—esophageal cancer	0.00561	0.00951	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00551	0.00933	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—esophageal cancer	0.00538	0.00912	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00533	0.00904	CcSEcCtD
Nalidixic Acid—Vertigo—Capecitabine—esophageal cancer	0.00507	0.0086	CcSEcCtD
Nalidixic Acid—Leukopenia—Capecitabine—esophageal cancer	0.00506	0.00857	CcSEcCtD
Nalidixic Acid—Arthralgia—Capecitabine—esophageal cancer	0.00481	0.00815	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—esophageal cancer	0.00465	0.00789	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC52A3—esophageal cancer	0.00463	0.0138	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—BLVRB—esophageal cancer	0.00463	0.0138	CbGpPWpGaD
Nalidixic Acid—Erythema multiforme—Methotrexate—esophageal cancer	0.00457	0.00774	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Capecitabine—esophageal cancer	0.00451	0.00765	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—esophageal cancer	0.00449	0.0076	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—esophageal cancer	0.00428	0.00725	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—esophageal cancer	0.0042	0.00712	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0042	0.00711	CcSEcCtD
Nalidixic Acid—Paraesthesia—Capecitabine—esophageal cancer	0.00414	0.00701	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—esophageal cancer	0.00398	0.00674	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—esophageal cancer	0.00394	0.00668	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—esophageal cancer	0.00394	0.00667	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CA1—esophageal cancer	0.00394	0.0117	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC10A2—esophageal cancer	0.00394	0.0117	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00392	0.0116	CbGpPWpGaD
Nalidixic Acid—Vertigo—Methotrexate—esophageal cancer	0.00378	0.0064	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00377	0.00639	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—esophageal cancer	0.00376	0.00638	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—esophageal cancer	0.00371	0.00629	CcSEcCtD
Nalidixic Acid—Urticaria—Capecitabine—esophageal cancer	0.00366	0.0062	CcSEcCtD
Nalidixic Acid—Abdominal pain—Capecitabine—esophageal cancer	0.00364	0.00617	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—esophageal cancer	0.00364	0.00617	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CA2—esophageal cancer	0.0036	0.0107	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00358	0.0106	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Methotrexate—esophageal cancer	0.00358	0.00606	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—esophageal cancer	0.00343	0.00581	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—esophageal cancer	0.00336	0.00569	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PLCE1—esophageal cancer	0.00335	0.00995	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ADH7—esophageal cancer	0.00335	0.00995	CbGpPWpGaD
Nalidixic Acid—Asthenia—Capecitabine—esophageal cancer	0.00331	0.0056	CcSEcCtD
Nalidixic Acid—Pruritus—Capecitabine—esophageal cancer	0.00326	0.00553	CcSEcCtD
Nalidixic Acid—Diarrhoea—Capecitabine—esophageal cancer	0.00315	0.00534	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00313	0.0053	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—esophageal cancer	0.00308	0.00522	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—esophageal cancer	0.00305	0.00517	CcSEcCtD
Nalidixic Acid—Dizziness—Capecitabine—esophageal cancer	0.00305	0.00516	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ADH1B—esophageal cancer	0.00294	0.00873	CbGpPWpGaD
Nalidixic Acid—Vomiting—Capecitabine—esophageal cancer	0.00293	0.00497	CcSEcCtD
Nalidixic Acid—Rash—Capecitabine—esophageal cancer	0.00291	0.00492	CcSEcCtD
Nalidixic Acid—Dermatitis—Capecitabine—esophageal cancer	0.0029	0.00492	CcSEcCtD
Nalidixic Acid—Headache—Capecitabine—esophageal cancer	0.00289	0.00489	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00281	0.00475	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—TYMP—esophageal cancer	0.00281	0.00834	CbGpPWpGaD
Nalidixic Acid—Nausea—Capecitabine—esophageal cancer	0.00274	0.00464	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP26A1—esophageal cancer	0.00273	0.00811	CbGpPWpGaD
Nalidixic Acid—Urticaria—Methotrexate—esophageal cancer	0.00273	0.00462	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—esophageal cancer	0.00271	0.0046	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ALOX15—esophageal cancer	0.00266	0.0079	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—TPI1—esophageal cancer	0.00254	0.00754	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTO1—esophageal cancer	0.00254	0.00754	CbGpPWpGaD
Nalidixic Acid—Asthenia—Methotrexate—esophageal cancer	0.00246	0.00417	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ALDOB—esophageal cancer	0.00243	0.00723	CbGpPWpGaD
Nalidixic Acid—Pruritus—Methotrexate—esophageal cancer	0.00243	0.00411	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—esophageal cancer	0.00235	0.00398	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GAPDH—esophageal cancer	0.00234	0.00696	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CRABP1—esophageal cancer	0.00232	0.0069	CbGpPWpGaD
Nalidixic Acid—Dizziness—Methotrexate—esophageal cancer	0.00227	0.00384	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00223	0.00664	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GNG7—esophageal cancer	0.00221	0.00656	CbGpPWpGaD
Nalidixic Acid—Vomiting—Methotrexate—esophageal cancer	0.00218	0.0037	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—esophageal cancer	0.00216	0.00367	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—esophageal cancer	0.00216	0.00366	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—esophageal cancer	0.00215	0.00364	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.0021	0.00624	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALDH2—esophageal cancer	0.00207	0.00615	CbGpPWpGaD
Nalidixic Acid—Nausea—Methotrexate—esophageal cancer	0.00204	0.00345	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00199	0.00592	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—esophageal cancer	0.00197	0.00585	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2A6—esophageal cancer	0.00194	0.00578	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.0019	0.00564	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ENO1—esophageal cancer	0.00184	0.00548	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS1—esophageal cancer	0.00184	0.00548	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00182	0.00541	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00182	0.00541	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PSME2—esophageal cancer	0.00182	0.0054	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PSME1—esophageal cancer	0.00182	0.0054	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP1B1—esophageal cancer	0.00157	0.00466	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP19A1—esophageal cancer	0.00147	0.00438	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00138	0.0041	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HMOX1—esophageal cancer	0.00134	0.004	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCB1—esophageal cancer	0.00129	0.00384	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00125	0.00372	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CREBBP—esophageal cancer	0.000863	0.00256	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NOS3—esophageal cancer	0.000772	0.0023	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000763	0.00227	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000732	0.00218	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—esophageal cancer	0.000707	0.0021	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—EP300—esophageal cancer	0.000588	0.00175	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000489	0.00145	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—esophageal cancer	0.000435	0.00129	CbGpPWpGaD
